Clinical Trials

In this article, triple detection SEC and MDRS are considered within the context of characterizing complex drug formulations, with specific case studies and results illustrating their application.

This article explains how dynamic light scattering (DLS) can be used to gather particle size distribution data for the successful use of nanosized colloidal gold in drug delivery applications.

Nominations for the 2017 Power List are now open and will close on February 1, 2017.

Sitting Down With... Ibraheem “Ibs” Mahmood, President and Chief Executive Officer, DrugDev, founded in the UK and headquartered in King of Prussia, PA, USA.

How difficult is it to develop a new drug? Statistics have the answer

The EMA says it will review its standards for first-in-human trials

Cell therapy successes are widely hailed as breakthroughs, but will adverse effects and patient deaths hold the field back?

Particle agglomeration can compromise the clinical efficacy of pharmaceutical products and must therefore be closely controlled. This article provides practical guidance on using automated imaging for efficient agglomerate detection.

OMNISEC measures the Critical Quality Attributes of polymeric pharmaceutical excipients with unrivalled sensitivity supporting their efficient use to formulate safe and effective pharmaceutical products.

Angus Dalgleish tells us about his experience with EU regulation – and why he thinks Britain should leave the EU.